FFM
IDXX icon

Fullerton Fund Management’s Idexx Laboratories IDXX Stock Holding History

Fullerton Fund Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-76,747
Closed -$25M – 84
2022
Q3 		$25M Buy
+76,747
New +$28.2M 1.86% 24
2022
Q1 		– Sell
-17,676
Closed -$11.6M – 67
2021
Q4 		$11.6M Buy
17,676
+6,426
+57% +$4.03M 0.58% 35
2021
Q3 		$7M Buy
+11,250
New +$7.56M 0.42% 38

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fullerton Fund Management's IDXX Position: Q4 2022 in Review

Fullerton Fund Management sold out of Idexx Laboratories (IDXX) in Q4 2022, closing a stake of 76,747 shares — an estimated $25M sold.

Fullerton Fund Management first reported a position in IDXX in Q3 2021 and held it in 3 quarters. The position peaked at $25M in Q3 2022. 999 funds tracked by Wall St. Rank hold IDXX as of Q4 2022.

  • Fullerton Fund Management reported no remaining Idexx Laboratories position as of Q4 2022 after selling out during the quarter.
  • Fullerton Fund Management sold 76,747 Idexx Laboratories shares in Q4 2022, an estimated $25M.
  • Fullerton Fund Management first reported a position in Idexx Laboratories in Q3 2021 and held it in 3 quarters.
  • Fullerton Fund Management's Idexx Laboratories position peaked at $25M in Q3 2022.
  • 999 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2022.

Based on Fullerton Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.